BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 15, 2019
Product Development

Chipping away at unreliable animal data

Emulate shows its Liver-Chip can predict clinical toxicities that don't occur in animal models
BioCentury | May 23, 2018
Distillery Techniques

Assays and screens; biomarkers

BioCentury | Feb 3, 2017
Clinical News

RG-101 regulatory update

BioCentury | Jul 18, 2016
Clinical News

RG-101: Additional Phase II data

BioCentury | Jul 11, 2016
Clinical News

RG-101: FDA hold

BioCentury | Jun 6, 2016
Company News

GlaxoSmithKline, Regulus deal

BioCentury | Jun 2, 2016
Translation in Brief

Setting boundaries

Stanford group finds toxicity ceiling for shRNA therapeutics
BioCentury | Apr 25, 2016
Clinical News

RG-101: Additional Phase II data

BioCentury | Feb 22, 2016
Clinical News

RG-101: Interim Phase II data

BioCentury | Feb 1, 2016
Clinical News

RG-101: Completed Phase II enrollment

Items per page:
1 - 10 of 34